The implementation date, when Medicare systems apply the edits, is July 6, 2026
When a compound is already producing 50 pounds of weight loss, adding a second compound that might produce an additional 4 to 5 pounds over a similar period starts to look like complexity for minimal gain
Charges will be based on examination and services provided during the visit
With practice, many patients find IM self-injection to be straightforward
Tirzepatide (Zepbound and Mounjaro): Weekly GLP-1/GIP injection Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics the activity of two natural hormones, glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, that regulate your appetite and metabolism
Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly
